By Carolyn Sung, CNN Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine, the companies said Saturday. The companies tested a vaccine that targets Omicron BA.
The Food and Drug Administration will have to decide the exact recipe, but a combination shot is expected that adds protection against a version of the omicron variant to the original vaccine.
The Food and Drug Administration is meeting on Tuesday to make an extremely difficult but important decision: Should vaccines be updated to target the omicron variant?
A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.
The US Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee voted Tuesday to support recommending inclusion of an Omicron-specific component for a Covid-19 booster vaccine.
U.S. regulators told COVID-19 vaccine makers Thursday that any booster shots tweaked for the fall will have to add protection against the newest omicron relatives.
The Food and Drug Administration on Thursday said vaccine manufacturers should update their Covid-19 booster shots to target the most recent omicron subvariants that are gaining round in the U.S. This is breaking news. Please check back for updates.
U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest versions of Omicron.
THURSDAY, June 30, 2022 (HealthDay News) -- The U.S. Food and Drug Administration announced Thursday that it has asked vaccine makers to update their COVID-19 booster shots to target the
U.S. regulators told COVID-19 vaccine makers Thursday that any booster shots tweaked for the fall will have to add protection against the newest omicron relatives.
